Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
Web of Science
AuthorSullivan, SG; Chilver, MB; Carville, KS; Deng, Y-M; Grant, KA; Higgins, G; Komadina, N; Leung, VKY; Minney-Smith, CA; Teng, D; ...
PublisherEUR CENTRE DIS PREVENTION & CONTROL
University of Melbourne Author/sSullivan, Sheena
Document TypeJournal Article
CitationsSullivan, S. G., Chilver, M. B., Carville, K. S., Deng, Y. -M., Grant, K. A., Higgins, G., Komadina, N., Leung, V. K. Y., Minney-Smith, C. A., Teng, D., Tran, T., Stocks, N. & Fielding, J. E. (2017). Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. EUROSURVEILLANCE, 22 (43), pp.2-8. https://doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707.
Access StatusOpen Access
In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References